Celia Rodríguez-Borjabad

Dr. Celia Rodríguez-Borjabad

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JGJosefa Girona-Tell
Josefa Girona-Tell
NANúria Amigó
Núria Amigó
DIDaiana Ibarretxe
Daiana Ibarretxe
NPNúria Plana
Núria Plana
CRCelia Rodríguez-Borjabad
Celia Rodríguez-Borjabad
LMLluís Masana
Lluís Masana
While cholesterol content in high-density lipoproteins (HDLs) is a well-established inverse marker of cardiovascular risk, the importance of HDL–triglyceride (HDL-TG) concentration is not well known. We aim to examine plasma HDL-TG concentrations, assessed by 1H-NMR, in patients with metabolic diseases and their association with classical biomarkers. In this cross-sectional study, we included 502 patients with type 2 diabetes or metabolic syndrome attending the lipid unit of our University Hospital. The presence of arteriosclerotic plaques was assessed by ultrasonography. A complete lipoprotein profile was performed by 1H-NMR (Liposcale test). HDL-TG was strongly positively correlated with total triglycerides, glycerol, and fatty liver index, while a strong negative correlation was observed with HDL-cholesterol (HDL-C) and HDL-particle number (HDL-P). HDL-TG was associated with all triglyceride-rich lipoprotein parameters and had an opposite association with HDL-C and HDL-P. It was also significantly correlated with circulating cholesterol ester transfer protein (CETP). HDL-TG concentrations were higher as metabolic syndrome components increased. HDL-TG was also higher with worsening glucose metabolism. Patients with carotid plaques also showed higher HDL-TG. In contrast to HDL-C, HDL-TG is directly associated with metabolism and arteriosclerotic vascular alterations. HDL-TG should be considered a biomarker of metabolic and cardiovascular risk and could be a marker of HDL dysfunction.

26 October 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JGJosefa Girona-Tell
Josefa Girona-Tell
CRCelia Rodríguez-Borjabad
Celia Rodríguez-Borjabad
DIDaiana Ibarretxe
Daiana Ibarretxe
JVJoan-Carles Vallvé
Joan-Carles Vallvé
RFRaimon Ferré
Raimon Ferré
LMLluís Masana
Lluís Masana
Background: Glucose-regulated protein 78/Binding immunoglobulin protein (GRP78/BiP) is a protein associated with endoplasmic reticulum stress and is upregulated by metabolic alterations at the tissue-level, such as hypoxia or glucose deprivation, and it is hyper-expressed in fat tissue of obese individuals. Objective: To investigate the role of the GRP78/BiP level as a metabolic and vascular disease biomarker in patients with type 2 diabetes (DM), obesity and metabolic syndrome (MS). Methods: Four hundred and five patients were recruited, of whom 52.5% were obese, 72.8% had DM, and 78.6% had MS. The intimae media thickness (cIMT) was assessed by ultrasonography. The plasma GRP78/BiP concentration was determined, and its association with metabolic and vascular parameters was assessed. Circulating GRP78/BiP was also prospectively measured in 30 DM patients before and after fenofibrate/niacin treatment and 30 healthy controls. Results: In the cross-sectional study, the GRP78/BiP level was significantly higher in the patients with obesity, DM, and MS. Age-, gender- and BMI-adjusted GRP78/BiP was directly associated with LDL-cholesterol, non-HDL-cholesterol, triglycerides, apoB, and cIMT. GRP78/BiP was positively associated to carotid plaque presence in the adjusted model, irrespective of obesity, DM and MS. In the prospective study, nicotinic acid treatment produced a significant reduction in the GRP78/BiP levels that was not observed with fenofibrate. Conclusions: GRP78/BiP plasma concentrations are increased in patients with both metabolic derangements and subclinical atherosclerosis. GRP78/BiP could be a useful marker of metabolic and cardiovascular risk.

1 March 2018 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
LMLluís Masana
Lluís Masana
JGJosefa Girona-Tell
Josefa Girona-Tell
DIDaiana Ibarretxe
Daiana Ibarretxe
RRRicardo Rodríguez-Calvo
Ricardo Rodríguez-Calvo
RRRoser Rosales
Roser Rosales
NPNúria Plana
Núria Plana

1 November 2018 in Atherosclerosis
Verified
Journal Article
Closed access
DIDaiana Ibarretxe
Daiana Ibarretxe
CRCelia Rodríguez-Borjabad
Celia Rodríguez-Borjabad
AFAlbert Feliu
Albert Feliu
JBJosé Ángel Bilbao
José Ángel Bilbao
LMLluís Masana
Lluís Masana
NPNúria Plana
Núria Plana

1 August 2019 in Atherosclerosis
Verified
Journal Article
Closed access
LMLluís Masana
Lluís Masana
DIDaiana Ibarretxe
Daiana Ibarretxe
CRCelia Rodríguez-Borjabad
Celia Rodríguez-Borjabad
NPNúria Plana
Núria Plana
PVPedro Valdivielso
Pedro Valdivielso
Xavier PintóXavier Pintó
Xavier Pintó

1 January 2018 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
JGJosefa Girona-Tell
Josefa Girona-Tell
CRCelia Rodríguez-Borjabad
Celia Rodríguez-Borjabad
DIDaiana Ibarretxe
Daiana Ibarretxe
MHMercedes Heras
Mercedes Heras
NANuria Amigo
Nuria Amigo
EZE. Zabala
E. Zabala